CDH6 and ovarian carcinoma: The in vitro antiproliferative activity of CUSP06 was evaluated in two CDH6-expressing human ovarian cancer cell lines, OVCAR-3 and PA-1, and one CDH6 null ovarian cancer line ES-2.